Fig. 6.

The impact of propofol in combination with cisplatin and doxorubicin on the cell cycle profile in human ovarian cells. (A-B) After treating SKOV3 and OVCAR3 cells with concentrations of propofol (0 and 50 µg/ml) in combination with either 10 µM cisplatin or 1 µM doxorubicin for 24 h, PI staining was performed, and the cells were analyzed using flow cytometry. The bars represent the mean ± SD of three independent experiments. Statistical significance is indicated by * for p < 0.05, ** for p < 0.01, and *** for p < 0.001, determined using Student’s t-tests